-+ 0.00%
-+ 0.00%
-+ 0.00%

SIONNA THERAPEUTICS ANNOUNCES INITIATION OF PRECISION CF PHASE 2A TRIAL EVALUATING NBD1 STABILIZER, SION-719, WHEN ADDED TO STANDARD OF CARE IN PARTICIPANTS WITH CYSTIC FIBROSIS

Reuters·10/21/2025 11:00:00

Please log in to view news